Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 symbols : Jnj save search
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
covid-19 sales drug
Global Self Testing Market Analysis Report 2023-2028: Breakdown by Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, & COVID-19 Testing
Published: 2023-11-08 (Crawled : 10:00) - prnewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.04%
H: 0.54%
C: -0.5%
QDEL | $40.26 -2.87% -2.96% 810K
|
Health Technology
|
| O: -0.15%
H: 1.46%
C: -1.98%
OSUR | $5.22 -3.51% -3.64% 550K
|
Health Technology
|
| O: 1.04%
H: 6.04%
C: 1.81%
covid-19 pregnancy report urine cholesterol blood global market
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 0.11%
H: 0.33%
C: -0.98%
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: -0.33%
TAK | $13.23 0.38% 0.0% 2.3M
|
Health Technology
|
| O: 0.44%
H: 0.22%
C: 0.07%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.55%
H: 0.3%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
covid-19
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19...
Published: 2023-10-05 (Crawled : 17:00) - biospace.com/
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda approval
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19 Vaccine
Published: 2023-10-05 (Crawled : 15:30) - biospace.com/
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda vaccine approval
Esperovax Awarded $1M for Development of an Oral COVID-19 RNA Vaccine under the HHS Project NextGen Initiative
Published: 2023-10-03 (Crawled : 17:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.26%
H: 0.53%
C: 0.43%
covid-19 initiative vaccine nextgen
COVID-19 Pandemic Spurs Demand for Personal Care Wipes: Market Expands at 6.3% CAGR, Led by Baby Wipes Segment
Published: 2023-09-13 (Crawled : 01:00) - prnewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.05%
H: 0.73%
C: 0.14%
EPC 4 | $35.46 -0.03% 0.0% 200K
|
Consumer Non-Durables
|
| O: 0.29%
H: 0.72%
C: -0.1%
covid-19 care baby market
House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship
Published: 2023-07-19 (Crawled : 15:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.72%
H: 1.58%
C: 0.53%
covid-19 potential house
Latin America Home Healthcare Market Worth $37.15 billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
Published: 2023-02-23 (Crawled : 15:20) - prnewswire.com
PHG | $20.33 -0.39% 0.0% 740K
|
Health Technology
|
| O: 1.19%
H: 0.27%
C: -0.24%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.04%
H: 0.55%
C: 0.01%
BSX | $68.12 1.01% 0.02% 6.6M
|
Health Technology
|
| O: 0.0%
H: 1.42%
C: 1.22%
BDX | $231.01 -1.58% 0.0% 1.1M
|
Health Technology
|
| O: -0.41%
H: 0.86%
C: 0.13%
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
|
| O: -0.9%
H: 0.98%
C: -0.32%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.54%
H: 0.52%
C: -0.67%
MASI | $138.16 0.04% 0.04% 350K
|
Health Technology
|
| O: 0.3%
H: 0.92%
C: -0.08%
covid-19 research america trends report impact home market
Global Pharmaceutical Packaging Market Report 2022-2027: Supply Chain Analysis, Technologies, Regulations, Future Trends, Impacts of COVID-19
Published: 2023-01-05 (Crawled : 12:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.77%
H: 0.75%
C: 0.75%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.62%
H: 0.54%
C: -0.12%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -1.28%
H: 0.35%
C: -0.29%
AMCR | $8.83 -1.23% 0.0% 6.8M
|
Process Industries
|
| O: -0.83%
H: 0.59%
C: -0.08%
covid-19 global report market
Bone Growth Stimulators Market Research Report by Product, Application, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-27 (Crawled : 15:00) - prnewswire.com
TRUMF | $16.504 -17.59% 1.7K
|
Health Technology
|
| O: -3.46%
H: 3.78%
C: 0.1%
TRUMY | $16.53 0.79% 31K
|
Manufacturing
|
| O: -4.65%
H: 3.58%
C: 2.81%
ZBH | $122.07 -1.56% 0.0% 1.6M
|
Health Technology
|
| O: 0.24%
H: 0.62%
C: 0.22%
SYK | $337.66 -0.43% 0.0% 1.2M
|
Health Technology
|
| O: 0.16%
H: 0.71%
C: 0.32%
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: 0.01%
H: 0.5%
C: 0.17%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.35%
H: 0.13%
C: -0.38%
covid-19 research global report impact bone distribution growth market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | $11.91 0.17% 0.17% 5.4M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO | $9.635 -12.33% -14.06% 750K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $67.32 -0.64% -0.64% 5M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.694 2.27% 2.22% 1M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $1.03 -1.91% -1.94% 1.2M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial
Published: 2022-10-17 (Crawled : 07:00) - globenewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
covid-19 candidate antibody vaccine six trial response phase 2
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 1.27%
H: 5.93%
C: 5.36%
covid-19 vaccine prototype
Trauma Implants Market Size Worth US$ 15.25 Billion by 2030 at 6.80% CAGR, COVID-19 Impact, and Global Analysis by Growth Plus Reports
Published: 2022-10-03 (Crawled : 15:20) - prnewswire.com
SNNUF | $12.07 -1.12% 480
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.16%
SYK | $337.66 -0.43% 0.0% 1.2M
|
Health Technology
|
| O: 1.4%
H: 2.83%
C: 2.17%
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: 0.93%
H: 2.13%
C: 1.47%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.6%
H: 0.05%
C: -0.66%
CNMD | $77.46 2.96% 0.0% 640K
|
Health Technology
|
| O: 1.27%
H: 2.34%
C: 0.64%
CNMD | $77.46 2.96% 0.0% 640K
|
Health Technology
|
| O: 1.27%
H: 2.34%
C: 0.64%
covid-19 global plus growth market
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate
Published: 2022-09-02 (Crawled : 20:00) - globenewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
| Email alert
Add to watchlist
covid-19 candidate global vaccine trial
Global MedTech Healthcare IT Industry Competitive Landscape Review 2021-2022: Technology, Impact of COVID-19, Regulatory Framework, Patent Review, Start-up Ecosystem
Published: 2022-08-25 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.504 -17.59% 1.7K
|
Health Technology
|
| O: 4.8%
H: 0.0%
C: -1.65%
TRUMY | $16.53 0.79% 31K
|
Manufacturing
|
| O: -1.65%
H: 4.07%
C: 4.07%
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: 0.81%
H: 2.42%
C: 2.38%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.19%
H: 0.68%
C: 0.62%
NNOX | $9.27 1.65% 1.62% 1.1M
|
Health Technology
|
| O: 1.42%
H: 0.33%
C: -0.94%
covid-19 patent global impact review
Veru Announces Appointment of Jason Davies to Lead EMEA, LATAM and APAC Infectious Disease Franchise for Veru International Focused on Hospitalized COVID-19 Patients
Published: 2022-08-19 (Crawled : 13:00) - globenewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.25%
H: 2.6%
C: 1.66%
VERU | $1.255 -17.97% -21.91% 3.2M
|
Health Technology
|
| O: -3.19%
H: 7.78%
C: -3.37%
covid-19 disease international
Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine
Published: 2022-08-18 (Crawled : 13:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
ARCT 4 | $30.15 2.87% 2.79% 390K
|
Health Technology
|
| O: 0.0%
H: 0.26%
C: -8.59%
arct-154 covid-19 vaccine
What Makes Omicron More Infectious Than Other COVID-19 Variants
Published: 2022-07-20 (Crawled : 15:20) - prnewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
covid-19
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.